CDER New August 19, 2016

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

 

August 18, 2016


New and Generic Drug Approvals

August 17, 2016

Drug Name Active Ingredient Dosage Form/Route Sponsor Submission Type
Aricept donepezil hydrochloride Tablet;Oral Eisai Inc Manufacturing Change or Addition
Farxiga dapagliflozin propanediol Tablet;Oral Astrazeneca Ab Labeling Revision
Invokamet canagliflozin; metformin hydrochloride Tablet;Oral Janssen Pharms Labeling Revision
Invokana canagliflozin Tablet;Oral Janssen Pharms Labeling Revision
Kinevac sincalide Injectable;Injection Bracco Manufacturing Change or Addition
Viekira Pak (Copackaged) dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir Tablet, Tablet;Oral Abbvie Inc Manufacturing Change or Addition
Xarelto rivaroxaban Tablet;Oral Janssen Pharms Labeling Revision
Xigduo Xr dapagliflozin propanediol; metformin hydrochloride Tablet, Extended Release;Oral Astrazeneca Ab Labeling Revision
Zembrace Symtouch sumatriptan succinate Solution;Subcutaneous Dr Reddys Labs Ltd Manufacturing Change or Addition

 

 

Searching the Orange Book is now faster and easier with our new mobile app!

Download Orange Book Express

 Download iOS App Download Android App Black


This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332) Powered by GovDelivery

Postingan terkait:

Belum ada tanggapan untuk "CDER New August 19, 2016"

Post a Comment